Cigarette smoking is still the most important avoidable cardiovascular risk factor. The World Health Organization estimates that 20.2% (34.1% male, 6.1% females) of the world's population aged !15 years were current smokers in 2015.
Recent data suggest that tobacco smoking may also increase the risk of atrial fibrillation. 3 Electronic cigarettes may be an effective way to assist with smoking cessation. A recent randomized trial demonstrated that electronic cigarettes were more effective for smoking cessation at one year than nicotine replacement therapy. 4 However, the smoking cessation rate was only 18%, and among participants with one-year abstinence, 80% of those in the e-cigarette group were still using electronic cigarettes. This brings up the question of whether this approach merely replaces one evil with another. Clearly, knowledge on the safety of electronic cigarettes is critical in answering this question.
Only very limited information is available on the toxicology of electronic cigarettes. 5 The toxicology depends on exposure of users and toxicants in electronic cigarette aerosols. Typical ingredients of e-liquids are propylene glycol, glycerol, mixed with concentrated flavours, and, optionally, a variable percentage of nicotine. Hundreds of potentially toxic and carcinogenic chemical components have been identified in the cartridges, refill solutions and aerosols of electronic cigarettes and include tobacco specific nitrosamines, carbonyls, volatile organic compounds, tobacco alkaloids, heavy metals, free radicals and reactive oxygen species. 6, 7 While tobacco related compounds may have similar toxicology to cigarettes, other compounds in particular related to the flavours, additives and electronic cigarette design features may raise additional safety concerns. As a result of the diversity of electronic cigarette device designs and e-liquids, it may be difficult to extrapolate toxicity findings between different electronic cigarette types until we have a better understanding of the key design features that modulate toxicant production in the aerosol. 5 In the current issue, Skotsimara et al. have systematically reviewed and meta-analysed published literature to investigate the cardiovascular effects and associated risk. 8 In order to investigate this, they searched Medline for studies with cardiovascular risk surrogate endpoints (blood pressure, heart rate, arterial stiffness, endothelial function) and cardiovascular outcome. A total of only 27 studies were eligible for inclusion in the systematic review and many used different study designs and electronic cigarette types. The authors attempted to match different electronic cigarette types by using the higher nicotine type and, where relevant, only the non-flavoured electronic cigarette type was included. From the two studies investigating acute effects on arterial stiffness, one showed a similar increase in arterial stiffness after acute electronic cigarette use as compared with after conventional cigarette smoking, while one showed no effect. With regard to acute effects on endothelial function as measured by flow mediated dilation only one study was available that also showed acute negative effects on endothelial function similar to cigarette smoking. More studies were available with regard to heart rate and blood pressure response, with several demonstrating acute increase and others no responses. Importantly, only one observational study was available on the association between electronic cigarette use and myocardial infarction risk. 9 The data from the National Health Interview Surveys demonstrated in a logistic regression analysis comparing data collected in 2014 (N ¼ 36,697) and 2016 (N ¼ 33,028) and analysed in 2017 and 2018 that there was significant risk associated with electronic cigarette use (odds ratio (OR): 1.8), albeit significantly lower than associated with active cigarette smokers (OR: 2.7).
The consecutively performed meta-analysis focused on haemodynamic effects of electronic cigarettes, namely blood pressure and heart rate, including studies that provided sufficient data. Based on 11 and seven studies, the analysis showed that electronic cigarettes acutely increased heart rate and both systolic and diastolic blood pressure, respectively. Only three studies investigated the long-term effects of electronic cigarettes. However, these three studies did not investigate the effects of electronic cigarettes per se but, rather, investigated what happened when people switched from tobacco smoking to electronic cigarettes. This showed that there was a significant decrease in systolic and diastolic blood pressure (by À7/-4 mmHg) when people quit active cigarette smoking and used electronic cigarettes instead.
While the review by Skotsimara et al. did not conclusively answer the question of how dangerous electronic cigarettes are, the paper clearly maps the limited available evidence and shows where the gaps in knowledge lie. It illustrates that not much is known about the long-term cardiovascular health effects of electronic cigarettes and much more research in this area is needed also considering the diversity of exposure levels, electronic cigarette design and e-liquids. For the time being, electronic cigarettes may surely be a good thing if only temporarily used for (successful) smoking cessation, paying a smaller price for achieving a greater good. This, however, may not be the case for the majority of electronic cigarette users. The prevalence of electronic cigarettes is high (in the order of 5% adults), in particular in young adults, and most users are current smokers. [10] [11] [12] Recent data shows that even exclusive use of e-cigarettes appears to result in measurable exposure to known tobacco-related toxicants, generally at lower levels than cigarette smoking. 13 However, the majority of electronic cigarette users also smoke cigarettes, leading to higher exposure levels of tobacco-related toxicants than cigarettes alone 13 plus exposure to electronic cigarette related toxicants, pointing towards significant public health concerns. What the health effects are of long-term exposure, whether active 14 or passive, 15 if used alone or together with conventional cigarettes, which components of electronic cigarette aerosols may be responsible for negative health effects, and whether these can be reversed or alleviated 16 need to be investigated.
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